Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical utility of mosaic and segmental aneuploid embryos in assisted reproduction.

Current opinion in obstetrics & gynecology·2026
Same author

Pembrolizumab-associated hemophagocytic lymphohistiocytosis in recurrent metastatic squamous cell carcinoma of the ovary arising in a teratoma.

Gynecologic oncology reports·2026
Same author

Possible drug reaction with eosinophilia and systemic symptoms after spironolactone therapy for clinical hyperandrogenism: a case report.

F&S reports·2026
Same author

A case report of total epidermal necrosis following mirvetuximab soravtansine extravasation.

Gynecologic oncology reports·2025
Same author

Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer.

Hematology/oncology clinics of North America·2025
Same author

Evaluation of a Quality-Improvement Initiative to Address Nutritional Anemia in Gynecologic Oncology.

O&G open·2025

Related Experiment Video

Updated: Jan 12, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.6K

Advances in Cervical Cancer.

Olivia W Foley1, Danielle Strom2, Emily M Hinchcliff1

  • 1Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA.

Hematology/Oncology Clinics of North America
|October 31, 2025
PubMed
Summary

Recent advances in cervical cancer treatment, including immunotherapy for metastatic and recurrent cases, offer improved outcomes and reduced morbidity. These new therapeutic modalities are changing the standard of care for this widespread disease.

Keywords:
Adjuvant chemotherapyCancer stagingCervical cancerChemoradiationImmunotherapySurgical approach

More Related Videos

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.2K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Related Experiment Videos

Last Updated: Jan 12, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.6K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.2K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Area of Science:

  • Gynecologic Oncology
  • Medical Oncology
  • Immunotherapy

Background:

  • Cervical cancer remains a significant global health challenge.
  • Limited treatment options and poor prognosis historically characterized advanced stages.
  • Recent years have seen substantial progress in therapeutic strategies.

Purpose of the Study:

  • To highlight recent advancements in cervical cancer treatment.
  • To discuss the impact of immunotherapy on patient care.
  • To review improvements in oncologic outcomes and morbidity.

Main Methods:

  • Review of recent clinical trials and therapeutic developments.
  • Analysis of immunotherapy's role in metastatic and recurrent cervical cancer.
  • Evaluation of changes in the standard of care.

Main Results:

  • Significant advances have been made across all stages and therapeutic modalities.
  • Immunotherapy has been introduced as a novel treatment option.
  • These advances promise improved oncologic outcomes and decreased morbidity.

Conclusions:

  • The introduction of immunotherapy has transformed the standard of care for advanced cervical cancer.
  • Ongoing therapeutic advancements offer hope for better patient prognoses.
  • Further research continues to refine treatment strategies for cervical cancer.